KFDKALKALPM 421.2507 3.2 16.33 - - MBPDB/BIOPEP β-Lg VIESPPEIN(+.98) 998.4407 -63.5 16.72 DeAm BIOPEP Κ-cas (NQ) STPTTE 635.3052 26.6 4.33 stimulates exocrine MBPDB Κ-cas pancreatic secretion, immunomodulatory, antimicrobial and 784.9221 -1.5 23.98 Ox (M) ACE-inhibitory LPQNIPPLTQTPVVVPPFLQPEVMGVSK β-cas KIPAVF 337.7172 5.2 17.34 Antimicrobial IIAEKTKIPAVF MBPDB β-Lg 658.0518 12.9 25.87 ACE-inhibitory LPQNIPPLTQTPVVVPPFLQPEVMGVSK MBPDB β-cas AMAASDISLL 496.3247 130.5 21.21 Antimicrobial SLAMAASDISLL MBPDB β-Lg DAQSAPL 701.3478 2.1 13.62 Antimicrobial DAQSAPLR β-Lg MBPDB Antimicrobial AASDISLLDAQSAPLR MBPDB ACE-inhibitory LDAQSAPLR ACE-inhibitory DAQSAPLRVY EMPFPKYPVEPF 740.8639 1.6 21.92 protective effects in MBPDB β-cas indomethacin-induced enteritis through preservation of goblet cells and improvement in wound healing, opioid, increases mMuc4 and MUC2 expression and small intestinal goblet cell density NSAEPE 646.2825 22.8 3.47 - - β-Lg
KFDKALKALPM 421.2507 3.2 16.33 β-Lg - - MBPDB/BIOPEP VIESPPEIN(+.98) 998.4407 -63.5 16.72 Κ-cas DeAm (NQ) BIOPEP STPTTE 635.3052 26.6 4.33 Κ-cas stimulates exocrine pancreatic secretion, immunomodulatory, antimicrobial and MBPDB 784.9221 -1.5 23.98 β-cas Ox (M) ACE-inhibitory LPQNIPPLTQTPVVVPPFLQPEVMGVSK KIPAVF 337.7172 5.2 17.34 β-Lg Antimicrobial IIAEKTKIPAVF MBPDB 658.0518 12.9 25.87 β-cas ACE-inhibitory LPQNIPPLTQTPVVVPPFLQPEVMGVSK MBPDB AMAASDISLL 496.3247 130.5 21.21 β-Lg Antimicrobial SLAMAASDISLL MBPDB DAQSAPL 701.3478 2.1 13.62 β-Lg Antimicrobial DAQSAPLR Antimicrobial AASDISLLDAQSAPLR MBPDB ACE-inhibitory LDAQSAPLR MBPDB ACE-inhibitory DAQSAPLRVY EMPFPKYPVEPF 740.8639 1.6 21.92 β-cas protective effects in indomethacin-induced enteritis through preservation of goblet cells and improvement in wound healing, opioid, increases mMuc4 and MUC2 expression and small intestinal goblet cell density MBPDB NSAEPE 646.2825 22.8 3.47 β-Lg - -
1-s2.0-S1756464617306618-mmc1.docx